Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

UFPT earnings analysis

Filed May 8, 2026 · Our reading of the company's report

The latest report

UFP Technologies reported Q1 2026 net sales of $154.2 million, a 4.1% increase compared to Q1 2025, primarily driven by a 5.9% increase in medical segment sales. Gross margin improved slightly to 28.8%, while diluted…

Read full summary

UFP Technologies reported Q1 2026 net sales of $154.2 million, a 4.1% increase compared to Q1 2025, primarily driven by a 5.9% increase in medical segment sales. Gross margin improved slightly to 28.8%, while diluted EPS increased to $2.24, surpassing estimates.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

30% Gross margin Operating margin Mar 2023 May 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Mar 2023 May 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$2.24
Gross margin
28.8%
Segment
Medical
Segment
Non-medical

What stood out

  • Revenue Growth

    Q1 2026 revenue increased to $154.2 million, up 4.1% from $148.1 million in Q1 2025.

  • EPS Beat

    Diluted EPS rose to $2.24, exceeding the estimated EPS of $2.28.

  • Medical Segment Performance

    Medical sales grew 5.9% to $143.4 million, highlighting strong demand.

  • Margin Improvement

    Gross margin slightly improved to 28.8% from 28.5% in Q1 2025.

  • Operating Cash Flow

    Operating cash flow was $3.2 million, reflecting solid profitability despite working capital changes.

  • Decreased Interest Expense

    Net interest expense decreased to $1.7 million from $2.8 million due to lower average debt.

What to watch

  • Labor Efficiency Issues

    Significant employee turnover at AJR due to E-Verify audits has decreased productivity.

  • Customer Concentration Risk

    Two customers contributed 46.9% of revenue, raising dependence concerns.

  • Tariff Uncertainties

    While effects of tariffs have decreased, future impacts remain uncertain following tariff refund processes.

Management's outlook

Outlook deferred to earnings press release / call.

Earlier filings 4

10-K · February 27, 2026

UFP Technologies reported full-year 2025 net sales of $602.8 million, up 19.5% year-over-year driven largely by acquisitions that contributed approximately $168.3 million; organic sales growth was 1.5%. Gross margin…

10-Q · November 7, 2025

UFP Technologies reported Q3 net sales of $154.558 million (three months ended September 30, 2025), up versus the prior-year quarter, with diluted EPS essentially flat at $2.11. Gross margin compressed to 27.7% while…

10-Q · May 12, 2025

UFP reported strong Q1 results with net sales of $148,148 (in thousands) vs $105,009 in Q1-2024 (+$43,139, +41.1%), operating income of $23,126 (in thousands) and diluted EPS of $2.21 (vs $1.64 prior year). Gross margin…

10-Q · May 10, 2024

UFP Technologies reported Q1 net sales of $105,009,000 (up $7,256,000 or 7.4% vs. Q1 2023 $97,753,000) and diluted EPS of $1.64 (vs. $1.27 in Q1 2023). Operating income rose to $15,924,000 (operating margin 15.2%) and…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.